Hepcidin expression and iron parameters change in Type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 93, Issue 1, 2011, Pages 43-48

  Jiang, Fang ^a   Sun, Zhen Zhen ^a   Tang, Yue Ting ^a   Xu, Chuanqing ^b   Jiao, Xiao Yang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b HANSHAN NORMAL UNIVERSITY   (China)

Author keywords

Ferritin; Hepcidin; IL 6; Type 2 DM

Indexed keywords

C REACTIVE PROTEIN; CREATININE; ERYTHROPOIETIN; FERRITIN; GLUCOSE; HEMOGLOBIN A1C; HEPCIDIN; INTERLEUKIN 6; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; IRON ABSORPTION; IRON METABOLISM; LEUKOCYTE COUNT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UREA NITROGEN BLOOD LEVEL;

AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; HUMANS; INTERLEUKIN-6; IRON; MALE; MIDDLE AGED;

EID: 79960480086     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.03.028     Document Type: Article

References (31)

1. Fernandez-Real J.M., Lopez-Bermejo A., Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002, 51:2348-2354.
2. Wolff S.P. Diabetes mellitus and free radicals free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993, 49:642-652.
3. Cooksey R.C., Jouihan H.A., Ajioka R.S., Hazel M.W., Jones D.L., Kushner J.P., et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 2004, 145:5305-5312.
4. Dandona P., Hussain M.A., Varghese Z., Politis D., Flynn D.M., Hoffbrand A.V. Insulin resistance and iron overload. Ann Clin Biochem 1983, 20(Pt 2):77-79.
5. Zacharski L.R., Ornstein D.L., Woloshin S., Schwartz L.M. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000, 140:98-104.
6. Sun L., Franco O.H., Hu F.B., Cai L., Yu Z., Li H., et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab 2008, 93:4690-4696.
7. Forouhi N.G., Harding A.H., Allison M., Sandhu M.S., Welch A., Luben R., et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007, 50(5):949-956.
8. Jehn M.L., Guallar E., Clark J.M., Couper D., Duncan B.B., Ballantyne C.M., et al. A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 2007, 165(9):1047-1054.
9. Ferrannini E. Insulin resistance, iron, and the liver. Lancet 2000, 355:2181-2182.
10. You S.A., Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 2005, 357:1-16.
11. Pickup J.C., Chusney G.D., Thomas S.M., Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000, 67:291-300.
12. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002, 99(7):4596-4601.
13. Beutler E. Iron storage disease: facts, fiction and progress. Blood Cells Mol Dis 2007, 39:140-147.
14. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
15. Sham R.L., Phatak P.D., Nemeth E., Ganz T. Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood 2009, 114:493-494.
16. Fernandez-Real J.M., Equitani F., Moreno J.M., Manco M., Ortega F., Ricart W. Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores. J Clin Endocrinol Metab 2009, 94:982-988.
17. Dandona P., Aljada A., Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004, 25:4-7.
18. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
19. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004, 113:1271-1276.
20. Fleming R.E. Iron and inflammation: cross-talk between pathways regulating hepcidin. J Mol Med 2008, 86:491-494.
21. Theurl I., Mattle V., Seifert M., Mariani M., Marth C., Weiss G. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 2006, 107:4142-4148.
22. Dallalio G., Law E., Means R.T. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006, 107:2702-2704.
23. Piperno A., Mariani R., Trombini P., Girelli D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol 2009, 15:538-551.
24. Chang J., Bird R., Clague A., Carter A. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients. Pathology 2007, 39:349-353.
25. Clairmont K.B., Czech M.P. Insulin injection increases the levels of serum receptors for transferrin and insulin-like growth factor-II/mannose-6-phosphate in intact rats. Endocrinology 1990, 127(4):1568-1573.
26. Shinzato T., Abe K., Furusu A., Harada T., Shinzato K., Miyazaki M., et al. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia. Med Sci Monit 2008, 14:431-437.
27. Facchini F.S. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 1998, 21:2190.
28. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001, 276:7806-7810.
29. Kulaksiz H., Fein E., Redecker P., Stremmel W., Adler G., Cetin Y. Pancreatic beta-cells express hepcidin, an iron-uptake regulatory peptide. J Endocrinol 2008, 197:241-249.
30. Pinto J.P., Dias V., Zoller H., Porto G., Carmo H., Carvalho F., et al. Hepcidin messenger RNA expression in human lymphocytes. Immunology 2010, 130:217-230.
31. Wang L., Cherayil B.J. Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity. J Innate Immun 2009, 1:455-464.